Table 2

Concurrent combinations of valvular heart disease in Sweden between 2003 and 2010

ASARMSMRPSPRTSTR
N%N%N%N%N%N%N%N%
AS36 3191002482 17.9 543 28.31849  9.9  54  2.2 13  2.0 37 12.3 206  7.1
AR2482  6.813 853100.0 117  6.11488  8.0  75  3.0 33  5.2 11  3.6 156  5.4
MS543  1.5117  0.81917100.0344  1.8   8  0.3  4  0.6 12  4.0  60  2.1
MR1849  5.11488 10.7 344 17.918 595100.0  47  1.9 33  5.2 38 12.6 830 28.8
PS54  0.175  0.5   8  0.447  0.32460100.0180 28.3 30  9.9  14  0.5
PR13  0.033  0.2   4  0.233  0.2 180  7.3637100.0  6 2.0  23  0.8
TS37  0.111  0.1  12  0.638  0.2  30  1.2  6  0.9302100.0  35  1.2
TR206  0.6156  1.1  60  3.1830  4.5  14  0.6 23  3.6 35 11.62885100.0
  • Number of cases with different combinations of concurrent valvular heart disease diagnoses in 2003–2010 and proportion of cases with each valve disease (columns) that were concurrent with each of the other seven valve diseases (rows). AS, aortic stenosis; AR, aortic regurgitation; MS, mitral stenosis; MR, mitral regurgitation; PS, pulmonary stenosis; PR, pulmonary regurgitation; TS, tricuspid stenosis; TR, tricuspid regurgitation.